Congress Topics
Asthma phenotyping : practical aspects
Asthma endotyping : is it worth doing ?
Severe asthma
Occupational asthma
Asthma in the athlete
Eosinophilic asthma
Non-eosinophilic asthma
Cluster analysis of asthma phenotypes
Th17 immune responses in Asthma
Innate Lymphocyte Type 2 driven Asthma
Aspirin Exacerbated Respiratory Disease
Personalized medicine: how to make it happen
Biomarkers of asthma
Targeting asthma therapy
Il5 versus IgE as a Therapeutics target in Asthma
Other cytokines antagonists
Causes and risk factors
Management and prevention
Lessons from Emergency Room Management of Asthma
Adherence to therapy: a major asthma management problem
Inhaler techniques
Initial treatment of asthma: when to introduce ICS ?
New inhalers
Future treatment of asthma
Non-pharmacologic asthma therapies
Efficacy of Bronchothermoplasty in Asthma
LAMA versus LABA for Asthma
Allergic Moderate to Severe Asthma Treatment Options
Impact of new Asthma Biologicals on Asthma Exacerbations and Lung Function
Under and overtreatment of asthma
Standards for the diagnosis of asthma
Pulmonary function tests
Asthma and rhinitis
Asthma and upper airways dysfunction
Obesity and asthma
Asthma and psychological problems
The asthma-COPD Overlap
Atopic dermatitis
Chronic Rhinosinusitis and Th2 inflammation
Airway inflammation
Epithelial dysfunction
Airway remodelling
Neurogenic factors
Bacterial infections
Viral infections
Other agents
Influence of vaccination
New GINA report
New GOLD report
Asthma-COPD overlap report
GINA-GOLD Implementation program
Induced sputum analysis
Exhaled NO measures
Asthma education and knowledge translation
Educational interventions in COPD
Motivational interview
Shared-decision making
The asthma action plan
Role of the expert-patient
Training educators
Inhaled corticosteroids
Leukotriene antagonists
Combination therapies (double and triple combinations)
Monoclonal antibodies
Incidence and prevalence of asthma in the world
Morbidity and mortality from asthma
Lung function decline and its determinants
Age and gender differences
Natural history of asthma: can it be altered
Asthma remissions
Doies the “hygiene hypothesis” still holds ?
Asthma and pregnancy
Asthma in the elderly
Managing Allergy & Asthma in Resource Poor Settings
War-time asthma: lessons from Syria
Asthma in children less than 5 years old
Asthma in teenagers
Current standards
Oral immunotherapy update
Role of SLIT in Asthma
New developments
Role in Asthma
Peanut Allergy Therapeutic Approaches
Food allergy
Venom Allergy
Drug Allergy
Treatment Paradigms for anaphylaxis
Pathopysiology- Similarities and Differences from Asthma
The Allergic March
New Therapies- Topical
New Therapies- Biologics
Allergy testing
Aero-allergens and airways
The ARIA initiative
Associated Conditions
Diagnostic Criteria
Differential Diagnosis
Treatment Options
Vitamin deficiency and nutritional factors
Smoking (direct and secondary)
Exposure to bacteria (microbiome)
Genetic factors
Assessment of severe asthma
Management of difficult-to-control asthma
Severe pediatric asthma
New monoclonal antibodies
Thermoplasty update
Can we predict response to therapies
New therapies to come
Workplace inhalants
Air pollution
Weather conditions (thunderstorms)
Climate change
Perception of asthma symptoms
Patients’ expectations
Patient opinions on asthma treatment
The expert patient
Role of Eosinophils in ACOS
Role of Th2 inflammation in ACOS
Heterogeneity of Immune Pathogenesis of Asthma and COPD
Assessment of Benefits of New LAMAs in Asthma and COPD
ICS plus LABA plus LAMA in Asthma and COPD
Role of new Biologicals in COPD
Shared Pathophysiology of Allergic Rhinitis and Asthma
Impact of Allergic Rhinitis Therapies in Asthma
Allergen Immunotherapy in Asthma
Sub Lingual Allergen Immunotherapy for Dust Mite in Asthma and Allergic Rhinitis
Safety of Subcutaneous versus Sublingual Immunotherapy in Asthma


Preliminary Program
List of Speakers
Abstract Submission
Final Program
ePoster Submission
back to top